Henry Schein, Inc.

Henry Schein provides healthcare products and services globally to dental practitioners, laboratories, and medical professionals. The company operates through two segments: Health Care Distribution and Technology and Value-Added Services. The Health Care Distribution segment offers dental products like infection-control products and equipment repair services. It also provides medical products such as pharmaceuticals, vaccines, and diagnostic tests. The Technology and Value-Added Services segment offers software, technology, and practice solutions for healthcare professionals. Henry Schein was founded in 1932 and is headquartered in Melville, New York.

Overview

Sector

Medical Distribution

Target Price

98.7 USD

Current Price

67.2 USD

Potential

47%

Strengths

With an appreciation Potential of 45.31%, based on our fundamental analysis, it suggests the stock may be undervalued.
Price to book ratio (2.48) is lower than the sector mean (35.33).
EV/EBITDA (10.61) is lower than the sector mean (40.52).
EV/EBIT (16.84) is lower than the sector mean.
Price to free cash flow (12.76) is lower than the sector mean.

Weaknesses

The company has high debt. Net Debt to EBITDA Ratio (2.36) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (14.30%) is significantly lower than the sector mean (33.87%).
EBITDA Margin (8.06%) appears relatively low.

Key Financial Data

Indicator	Value
PER	21.4
EV/EBITDA	10.5
Price/Free Cash Flow'	12.6
ROIC	14.3%
Net Debt/EBITDA	2.4